Lecithin - Stabilized Microemulsion: An Organogel for Topical Application of Ketorolac Tromethamine. I: Phase Behavior Studies

Authors

  • AA Nasseri
  • H Zia
  • R Aboofazeli
  • TE Needham
Abstract:

The partial phase behavior of systems composed of lecithin/isopropyl myristate (IPM)/water or ketorolac tromethamine (KT) solutions (2.5, 5, 10 and 50% w/w) at various lecithin/IPM weight ratios (km) have been investigated by the construction of phase diagrams. A commercially available soybean lecithin (namely, Epikuron 200, phosphatidylcholine purity greater than 95%) was used in this study. Phase diagrams showed a narrow area of existence of a non-birefringent, transparent isotropic region along the lecithin / IPM axis in all systems, regardless of the km. The isotropic regions were stable for a minimum of 3 months at room temperature. The surfactant/oil ratio required for maximum KT incorporation has its minimum value in systems prepared with 50% KT solution, whereas the maximum value is obtained when a 2.5% KT solution was incorporated into the gel matrix. The results have also showed that for a given system, as km increases, the incorporation capacity increases. No significant differences in phase behavior were noted when altering the concentration of KT solution from 2.5 – 10%. However, a small decrease in the extent of the gel region was observed when 50% drug solution was incorporated into the system.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Lecithin - Stabilized Microemulsion - Based Organogels for Topical Application of Ketorolac Tromethamine. II. Invitro Release Study

Ketorolac tromethamine (KT) containing microemulsion-based gels (MBGs) have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant (soybean lecithin; Epikuron 200) and oil (isopropyl myristate; IPM) and the effect of formulation variables on the release profile of the drug from MBGs through intact guinea pig skin and various artificial membr...

full text

Lecithin - Stabilized Microemulsion - Based Organogels for Topical Application of Ketorolac Tromethamine. II. Invitro Release Study

Ketorolac tromethamine (KT) containing microemulsion-based gels (MBGs) have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant (soybean lecithin; Epikuron 200) and oil (isopropyl myristate; IPM) and the effect of formulation variables on the release profile of the drug from MBGs through intact guinea pig skin and various artificial membr...

full text

lecithin - stabilized microemulsion - based organogels for topical application of ketorolac tromethamine. ii. invitro release study

ketorolac tromethamine (kt) containing microemulsion-based gels (mbgs) have been formulated, based on the previous phase diagram studies, using a pharmaceutically acceptable surfactant (soybean lecithin; epikuron 200) and oil (isopropyl myristate; ipm) and the effect of formulation variables on the release profile of the drug from mbgs through intact guinea pig skin and various artificial membr...

full text

Topical Delivery of Flurbiprofen from Pluronic Lecithin Organogel

The purpose of this research is to formulate and evaluate the suitability of pluronic lecithin organogels containing flurbiprofen for topical application. Four formulations were developed using flurbiprofen, lecithin, Pluronic F127, isopropyl palmitate, water, sorbic acid and potassium sorbate were coded as FL1, FL2, FL3 and FL4. All the formulations carried 30% w/w of lecithin phase and 70% w/...

full text

[Eyelid contact allergic eczema caused by topical ketorolac tromethamine 0.5%].

CLINICAL CASE A 65-year-old man had been treated with eye-drops containing NSAIDs (Ketorolac). He developed conjunctival injection, edematous swelling of the eyelids and periorbital dermatitis due to a contact allergy. Allergy to NSAIDs is uncommon. DISCUSSION This is an unusual case because topical application of ketorolac is safe in the vast majority of ophthalmologic patients. However adve...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume Volume 2  issue Number 1

pages  59- 63

publication date 2010-11-20

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023